We’re adding to our geopolitical hedge and a struggling health-care stock
We’re adding to our lone oil stock and an out-of-favor medical-technology company.
We’re adding to our lone oil stock and an out-of-favor medical-technology company.
The reported new offering would come at an opportune time for the kingdom, which is spending heavily on megaprojects while seeing lower oil revenue.
The Chevron-Hess deal was originally slated to close in the first half of 2024, but that timeline has been delayed due to a dispute with Exxon Mobil.
Oil market analysts are broadly expecting OPEC+ to maintain its current production levels.
The Energy Department’s move to sell 1 million barrels of gasoline from the Northeast Gasoline Supply Reserve may not provide much relief at the pump.
WTI and Brent are on pace for a weekly loss of about 4% and 3%, respectively.
U.S. crude oil is down 2.4% for the week while Brent, the global benchmark, is down 1.8%.
A federal judge in Texas said Exxon Mobil’s lawsuit to bar a climate change proposal from activist investor Arjuna Capital can proceed.
A Texas man illicitly bought stock of a company eyed by oil giant BP after hearing his mergers and acquisitions executive wife discuss the deal on calls.